Informed consent, price transparency, and disclosure
In the American medical system, patients do not know the final price of treatment until long after the treatment is given, at which point it is too late to say “no.” I argue that without price disclosure many, perhaps all, tokens of consent in clinical medicine fall below the standard of valid, info...
| Main Author: | |
|---|---|
| Format: | Electronic Article |
| Language: | English |
| Check availability: | HBZ Gateway |
| Journals Online & Print: | Drawer...
|
| Fernleihe: | Fernleihe für die Fachinformationsdienste |
| Published: |
Wiley-Blackwell
2023
|
| In: |
Bioethics
Year: 2023, Volume: 37, Issue: 8, Pages: 741-747 |
| IxTheo Classification: | KBQ North America NCE Business ethics NCH Medical ethics |
| Further subjects: | B
Informed Consent
B price transparency B Disclosure B Cost B Reasonable Person |
| Online Access: |
Presumably Free Access Volltext (lizenzpflichtig) Volltext (lizenzpflichtig) |